These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
445 related items for PubMed ID: 11041909
21. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis. Hochberg MC. Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069 [Abstract] [Full Text] [Related]
23. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. Laine L, Harper S, Simon T, Bath R, Johanson J, Schwartz H, Stern S, Quan H, Bolognese J. Gastroenterology; 1999 Oct; 117(4):776-83. PubMed ID: 10500058 [Abstract] [Full Text] [Related]
30. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ, Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group. JAMA; 2002 Jan 02; 287(1):64-71. PubMed ID: 11754710 [Abstract] [Full Text] [Related]
31. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. Hochberg MC. Curr Top Med Chem; 2005 Jan 02; 5(5):443-8. PubMed ID: 15974939 [Abstract] [Full Text] [Related]
35. Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trials. Goldstein JL, Bello AE, Spalding W, Suh S, Fort JG. J Rheumatol; 2005 Jan 02; 32(1):111-7. PubMed ID: 15630735 [Abstract] [Full Text] [Related]